AbCellera Overview

  • Founded
  • 2012

Founded
  • Status
  • Public

  • Employees
  • 386

Employees
  • Stock Symbol
  • ABCL

Stock Symbol
  • Investments
  • 6

  • Share Price
  • $10.27

  • (As of Monday Closing)

AbCellera General Information

Description

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 2215 Yukon Street
  • Vancouver, British Columbia V5Y 0A1
  • Canada
+1 (604) 000-0000

AbCellera Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AbCellera Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.27 $10.65 $5.42 - $22.63 $3.03B 285M 2.51M $0.72

AbCellera Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 2,078,845 3,303,197 10,746,359
Revenue 489,063 375,203 233,155 11,612
EBITDA 306,731 238,294 169,322 (310)
Net Income 204,818 153,464 118,918 (2,211)
Total Assets 1,592,289 1,318,569 1,005,536 23,488
Total Debt 40,276 40,065 4,390 6,891
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AbCellera Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AbCellera‘s full profile, request access.

Request a free trial

AbCellera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various othe
Biotechnology
Vancouver, Canada
386 As of 2021
00000
0.000 0000-00-00
00000000 00000

000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
0000 000000000
San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

000000

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000000000000
South San Francisco, CA
00 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AbCellera Competitors (55)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vir Formerly VC-backed San Francisco, CA 000 00000 000000 - 000 00000
00000000000 000 Formerly VC-backed South San Francisco, CA 00 000000&0
00000000 000000 Formerly VC-backed Emeryville, CA 000 00000 00000000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
You’re viewing 5 of 55 competitors. Get the full list »

AbCellera Executive Team (15)

Name Title Board Seat Contact Info
Andrew Booth Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Veronique Lecault Founder & Chief Operating Officer, Operations
Tryn Stimart Secretary, Administration & Chief Compliance Officer, Legal
Kathleen Lisaingo Ph.D Co-Founder and Director, Discovery Technologies
Daniel Da Costa Co-Founder & Engineering Lead
You’re viewing 5 of 15 executive team members. Get the full list »

AbCellera Board Members (8)

Name Representing Role Since
Andrew Lo AbCellera Board Member 000 0000
John Hamer Ph.D Self Board Member 000 0000
John Montalbano Self Board Member 000 0000
Michael Hayden Ph.D Self Board Member 000 0000
Michael Hayden Ph.D Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

AbCellera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AbCellera Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AbCellera‘s full profile, request access.

Request a free trial

AbCellera Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000 10-Sep-2021 0000000000 0000 Drug Discovery 000000 00
000000 000000 25-Jan-2021 0000 00000 000 Drug Discovery
0000000 18-Nov-2020 0000000000 0000 Drug Delivery 0000 0000
000000 30-Sep-2020 00000 0000 000.00 Drug Discovery 0000 0000
Dualogics (OrthoMab) 20-Aug-2020 Merger/Acquisition Biotechnology 0000 0000
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

AbCellera Subsidiaries (2)

Company Name Industry Location Founded
Trianni Drug Delivery San Francisco, CA 2008
0000000000000 Drug Discovery Arlington, MA 0000
To view AbCellera’s complete subsidiaries history, request access »